• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从经济学角度看儿科放射肿瘤学面临的当前挑战。

Current challenges facing pediatric radiation oncology viewed through an economics lens.

机构信息

Department of Radiation Oncology, Pediatrics, and History, New York Medical College and the Touro College and University System, Valhalla, New York.

出版信息

Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28686. doi: 10.1002/pbc.28686. Epub 2020 Sep 29.

DOI:10.1002/pbc.28686
PMID:32991071
Abstract

This commentary addresses two problems facing pediatric radiation oncology: workforce education and the cost of technology. The tools of economics can help us understand these problems. Because cancer in children is relatively infrequent and the role of pediatric radiotherapy (RT) is limited, there are a small number of cases of children requiring RT in the US compared to the number of radiation oncology trainees. This creates a paucity of necessary clinical training material. Proton RT, rather than photon RT, is being recommended in many situations when RT is indicated in children. Cost, however, is a significant concern. The arguments for and against proton RT continue and a consensus on this matter has not emerged.

摘要

本述评探讨了儿科放射肿瘤学面临的两个问题

劳动力教育和技术成本。经济学工具可以帮助我们理解这些问题。由于儿童癌症相对罕见,且儿科放射治疗(RT)的作用有限,与接受放射肿瘤学培训的人数相比,美国需要接受 RT 的儿童病例数量较少。这导致必要的临床培训材料稀缺。在 RT 适用于儿童的许多情况下,建议使用质子 RT,而不是光子 RT。然而,成本是一个重大关注点。关于质子 RT 的利弊的争论仍在继续,对此事尚未达成共识。

相似文献

1
Current challenges facing pediatric radiation oncology viewed through an economics lens.从经济学角度看儿科放射肿瘤学面临的当前挑战。
Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28686. doi: 10.1002/pbc.28686. Epub 2020 Sep 29.
2
Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No.在质子束治疗被更广泛采用之前,是否需要阳性的III期临床试验数据?不需要。
Radiother Oncol. 2008 Feb;86(2):148-53. doi: 10.1016/j.radonc.2007.12.024. Epub 2008 Jan 30.
3
HERO (Health Economics in Radiation Oncology): a pan-European project on radiotherapy resources and needs.HERO(放射肿瘤学中的卫生经济学):一项关于放疗资源与需求的泛欧项目。
Clin Oncol (R Coll Radiol). 2015 Feb;27(2):115-24. doi: 10.1016/j.clon.2014.10.010. Epub 2014 Nov 20.
4
Comparative effectiveness research in radiation oncology: assessing technology.放射肿瘤学中的比较效果研究:评估技术。
Semin Radiat Oncol. 2014 Jan;24(1):25-34. doi: 10.1016/j.semradonc.2013.08.003.
5
Catching the proton wave.捕捉质子波。
Hosp Health Netw. 2007 Mar;81(3):62, 64, 66, 2.
6
Technology watch: proton beam therapy: is the market ready?
Healthc Leadersh Manag Rep. 2000 Aug;8(8):6-10.
7
Reducing Anesthesia and Health Care Cost Through Utilization of Child Life Specialists in Pediatric Radiation Oncology.通过在儿科放射肿瘤学中利用儿童生活专家来降低麻醉和医疗保健成本。
Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):401-405. doi: 10.1016/j.ijrobp.2016.06.001. Epub 2016 Jun 5.
8
Health economics in radiation oncology: introducing the ESTRO HERO project.放射肿瘤学中的健康经济学:ESTRO HERO 项目介绍。
Radiother Oncol. 2012 Apr;103(1):109-12. doi: 10.1016/j.radonc.2011.12.026. Epub 2012 Feb 8.
9
Training and education of pediatric radiation oncologists: A survey from the 2019 Pediatric Radiation Oncology Society meeting.儿科放射肿瘤学家的培训和教育:来自 2019 年儿科放射肿瘤学会会议的调查。
Pediatr Blood Cancer. 2020 Oct;67(10):e28619. doi: 10.1002/pbc.28619. Epub 2020 Aug 13.
10
High-tech in radiation oncology: should there be a ceiling?放射肿瘤学中的高科技:是否应该有上限?
Int J Radiat Oncol Biol Phys. 2004 Feb 1;58(2):320-30. doi: 10.1016/j.ijrobp.2003.09.057.